Company Filing History:
1 out of 33 
1 out of 7 
1 out of 215 
Years Active: 2017
Title: The Innovative Contributions of Marc Le Borgne
Introduction
Marc Le Borgne is a notable inventor based in Saint Germain au Mont d'or, France. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on phenazine derivatives. His research focuses on developing novel compounds that serve as anti-neoplastic and anti-infective agents.
Latest Patents
Marc Le Borgne holds a patent for "Phenazine derivatives as anti-neoplastic agents and anti-infective agents." This patent details the preparation and medical applications of novel phenazine derivatives, which are crucial in the fight against cancer and infections. The patent also includes methods for the preparation of iodinin and myxin, showcasing his commitment to advancing medical science. He has 1 patent to his name.
Career Highlights
Throughout his career, Marc has worked with esteemed institutions such as Universitetet I Oslo and Bergen Teknologioverføring AS. His experience in these organizations has allowed him to collaborate with leading experts in the field, further enhancing his research capabilities.
Collaborations
Some of Marc's notable coworkers include Stein Ove Døskeland and Pål Rongved. Their collaborative efforts have contributed to the advancement of research in medicinal chemistry and the development of innovative therapeutic agents.
Conclusion
Marc Le Borgne's work exemplifies the impact of innovative research in the medical field. His contributions through patents and collaborations highlight the importance of continued exploration in the development of effective treatments.